MedTrace Logo

Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy

NCT02123017 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-02-24

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the efficacy and safety of bisacodyl combined with escalating doses of lactulose to be used as a preparation for colonoscopy.

Conditions

  • Colonoscopy Preparation

Interventions

DRUG

90 grams of Crystalline Lactulose

15 mg of bisacodyl, plus 30 grams crystalline lactulose x 3 doses

DRUG

135 grams of Crystalline Lactulose

15 mg of bisacodyl, plus 45 grams crystalline lactulose x 3 doses

DRUG

180 grams of Crystalline Lactulose

15 mg of bisacodyl, plus 60 grams crystalline lactulose x 3 doses

Sponsors & Collaborators

  • Cumberland Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Richard Krause, MD · ClinSearch, LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02123017 on ClinicalTrials.gov